Telehealth Is Here to Stay: But How Do You Find the Right Markets?

The challenges healthcare executives and administrators face are constantly changing. Host Kevin Stevenson talks with the heroes behind the heroes that are enabling hospitals, urgent care centers and telemedicine operators to spend their time tending to patients, while they handle the logistics.

 

There’s no denying the importance of technology in healthcare; in fact, it became even more critical in the last year. With so many opportunities to improve care delivery, it’s about getting the right products to market. That’s the focus on Aaron Call, Founder of Jaunt. He joined I Don’t Care and host Kevin Stevenson to talk about this dynamic. Call is a long-time med-tech startup pioneer. Jaunt connects businesses with investors through data-backed insights and models.

“We work on early-stage companies and focusing on what can be improved for healthcare and then how to commercialize,” Call explained.

“It amazed me. There were so many economic benefits. It was the payers holding it up in many ways, and the pandemic adjusted this.” – Aaron Call

While telehealth is certainly the buzziest tech in the space, it’s not the only field Jaunt specializes in, but Call and his team worked with telemed platforms differentiate.

“Years ago, we saw that most companies were just SaaS products, not much different than Zoom. We helped a client realize there was a need for much more robust tools for such a system,” Call noted.

Call also noted the U.S. had little adoption pre-pandemic. “It amazed me. There were so many economic benefits. It was the payers holding it up in many ways, and the pandemic adjusted this.”

Jaunt realized that what they were doing for companies with market analysis and commercialization strategies was what investors were seeking in due diligence. “We’re serving up information from a third party that startups can use to go to investors, and the investors know us as a trusted source.”

Call said that the pandemic didn’t dry up investment, as they first expected. What it did do is change approaches to commercialization, sales models, and predictive market analytics.

He also shared what’s exciting him in the space right now. “Personalized health with data and tech behind it is exciting. Digital health that can help change behaviors and improve life is also big right now.”

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

Doable
Rethinking Leadership: Why “Doable” Might Be the Most Powerful Strategy in Education Today
April 3, 2026

At a time when educator burnout is rising and schools across the U.S. are facing ongoing teacher shortages, leaders are being forced to rethink what sustainable success actually looks like. Research shows that teacher attrition is closely tied to working conditions, job-related stress, and workload demands. As districts push for innovation, data-driven instruction, and…

Read More
Casey Brown
From Poverty to Pricing Power | Why Great Companies Undercharge
April 2, 2026

Casey Brown didn’t grow up thinking she would become an entrepreneur. She grew up in a blue-collar family where money was always tight — close enough to the edge that the fear of poverty shaped many of her early decisions. That fear led her into engineering, into corporate America, and eventually into a moment…

Read More
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
April 2, 2026

In this episode of Care Anywhere, host Lea Sims sits down with Nigerian nurse entrepreneur and advocate Obafemi Arowosegbe to discuss leadership, mentorship, and the future of nursing in Africa. While still a nursing student, Obafemi founded the Nightingale Summit, a growing conference designed to empower nursing students and early-career nurses with leadership skills,…

Read More
Oncology
From Denial to Access: Rethinking Oncology Care Through AI, Clinical Trials, and Patient-Centered Innovation
April 1, 2026

The rapid expansion of precision medicine, biologics, and targeted cancer therapies is transforming oncology—but it’s also overwhelming a system not built to keep pace. In the U.S., cancer drugs now account for some of the highest-cost treatments in healthcare, and with that has come a surge in prior authorization requirements and denials. Studies suggest physicians…

Read More